Lv2
170 积分 2025-03-04 加入
Discovery and Optimization of a Potent, Efficacious, and Brain-Penetrant Inhibitor of KRAS G12C
8天前
已完结
Discovery and Characterization of Divarasib (GDC-6036), a Potent Covalent Inhibitor of KRAS G12C
8天前
已完结
MYC in cancer: from undruggable target to clinical trials
24天前
已完结
Targeting DNA damage in ageing: towards supercharging DNA repair
24天前
已完结
Metabolites as agents and targets for cancer immunotherapy
24天前
已完结
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
24天前
已完结
How multispecific molecules are transforming pharmacotherapy
24天前
已完结
RNA modification systems as therapeutic targets
24天前
已完结
Synthetic lethality in cancer drug discovery: challenges and opportunities
24天前
已完结
Discovery and Optimization of Orally Bioavailable Heterobifunctional Degraders of KAT2A/B for the Treatment of Cancer
1个月前
已完结
皖公网安备34019202002308
